Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

236.34
-4.0900-1.70%
Post-market: 236.340.00000.00%19:44 EDT
Volume:697.42K
Turnover:166.80M
Market Cap:6.62B
PE:-3.62
High:255.00
Open:250.00
Low:235.56
Close:240.43
Loading ...

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow Jones
·
Yesterday

Q1 2025 Bio Rad Laboratories Inc Earnings Call

Thomson Reuters StreetEvents
·
02 May

Stock Track | Bio-Rad Laboratories Soars 6.06% After Beating Q1 Earnings Expectations

Stock Track
·
02 May

RBC Cuts Price Target on Bio-Rad Laboratories to $392 From $409, Keeps Outperform Rating

MT Newswires Live
·
02 May

Bio-Rad Laboratories Q1 Adjusted Earnings Rise, Revenue Falls

MT Newswires Live
·
02 May

Bio Rad Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

Zacks
·
02 May

Bio-Rad Laboratories Expects 2025 Non-GAAP Revenue to Range From 1% Drop to 1.5% Growth Vs. Prior Est 1.5% to 3.5% Gain

MT Newswires Live
·
02 May

Bio-Rad: Q1 Earnings Snapshot

Associated Press Finance
·
02 May

BRIEF-Bio-Rad Q1 Adjusted EPS USD 2.54 Vs. IBES Estimate USD 1.81

Reuters
·
02 May

Bio-Rad Q1 EPS USD 2.29

THOMSON REUTERS
·
02 May

Bio Rad Laboratories Inc - Sees FY25 Non-Gaap Operating Margin of About 10.0 to 12.0 Percent

THOMSON REUTERS
·
02 May

Bio-Rad Q1 Adjusted EPS USD 2.54 VS. Ibes Estimate USD 1.81

THOMSON REUTERS
·
02 May

Bio-Rad Q1 Gross Margin 52.3%

THOMSON REUTERS
·
02 May

Bio Rad Laboratories Inc - Expects FY25 Non-Gaap, Currency-Neutral REV to Range From About a 1.0 Percent Decline to 1.5 Percent Growth

THOMSON REUTERS
·
02 May

Bio-Rad Reports First-Quarter 2025 Financial Results

Business Wire
·
02 May

Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential

Insider Monkey
·
30 Apr

Bell Potter Keeps Their Buy Rating on Biome Australia Ltd (BIO)

TIPRANKS
·
29 Apr

BIO-key regains compliance with Nasdaq

TIPRANKS
·
25 Apr

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

GlobeNewswire
·
25 Apr